eli lilly retatrutide clinical trials orforglipron oral GLP-1 phase 3 weight loss trial Eli Lily, is beginning to

Use a calculator, double-check your math, and when in doubt, start with less rather than more

Safety and Medical Guidance Everything in this article is educational

The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced supply constraints in recent months as the drugs get expanded approval from health regulators and increased health coverage

Some women achieve excellent results at the 8mg dose without needing to escalate to 12mg

First description in humans of the ability of SGLT2 inhibitors to attenuate glomerular hyperfiltration, likely by affecting tubuloglomerular feedback mechanisms

Allergic reactions including rash, swelling of the face or throat, or difficulty breathing